GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Asset Turnover

Orion Pharma (DHA:ORIONPHARM) Asset Turnover : 0.03 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Orion Pharma's Revenue for the three months ended in Sep. 2024 was BDT1,647 Mil. Orion Pharma's Total Assets for the quarter that ended in Sep. 2024 was BDT53,484 Mil. Therefore, Orion Pharma's Asset Turnover for the quarter that ended in Sep. 2024 was 0.03.

Asset Turnover is linked to ROE % through Du Pont Formula. Orion Pharma's annualized ROE % for the quarter that ended in Sep. 2024 was 1.04%. It is also linked to ROA % through Du Pont Formula. Orion Pharma's annualized ROA % for the quarter that ended in Sep. 2024 was 0.41%.


Orion Pharma Asset Turnover Historical Data

The historical data trend for Orion Pharma's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Asset Turnover Chart

Orion Pharma Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.27 0.21 0.28 0.20

Orion Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.04 0.04 0.05 0.03

Competitive Comparison of Orion Pharma's Asset Turnover

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Asset Turnover Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Asset Turnover falls into.



Orion Pharma Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Orion Pharma's Asset Turnover for the fiscal year that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2024 )/( (Total Assets (A: Jun. 2023 )+Total Assets (A: Jun. 2024 ))/ count )
=10620.866/( (52939.683+53185.508)/ 2 )
=10620.866/53062.5955
=0.20

Orion Pharma's Asset Turnover for the quarter that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=1646.542/( (53185.508+53783.08)/ 2 )
=1646.542/53484.294
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Orion Pharma  (DHA:ORIONPHARM) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Orion Pharma's annulized ROE % for the quarter that ended in Sep. 2024 is

ROE %**(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=221.584/21285.954
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(221.584 / 6586.168)*(6586.168 / 53484.294)*(53484.294/ 21285.954)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.36 %*0.1231*2.5127
=ROA %*Equity Multiplier
=0.41 %*2.5127
=1.04 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Orion Pharma's annulized ROA % for the quarter that ended in Sep. 2024 is

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=221.584/53484.294
=(Net Income / Revenue)*(Revenue / Total Assets)
=(221.584 / 6586.168)*(6586.168 / 53484.294)
=Net Margin %*Asset Turnover
=3.36 %*0.1231
=0.41 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Orion Pharma Asset Turnover Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines